Quick Post: A Look at SPDR S&P Biotech ETF
Biotech stocks have not performed well for many months now. The sector soared in 2020 and peaked in early 2021. Despite high hopes for the industry due to vaccine development and impacts of Covid-19, stocks in the industry plunged or languished with no end in sight. The current bear market adds more pain to biotech …
Continue reading ‘Quick Post: A Look at SPDR S&P Biotech ETF’ »